ArticleRespiratory medicine case reports2026
Coexistence of sarcoidosis and systemic sclerosis with nailfold videocapillaroscopy documentation.
Article in Respiratory medicine case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcoidosis and systemic sclerosis (SSc) are both rare multisystem disorders whose aetiology is not fully understood. Their coexistence is uncommon but clinically significant. Nailfold videocapillaroscopy (NVC) is a validated non-invasive technique for assessing peripheral microvascular involvement in SSc, and its potential utility in sarcoidosis/SSc overlap has not been systematically reported. Case presentation: We report a 62-year-old female non-smoker with confirmed SSc (anti-Scl-70 positive, anti-Pm/Scl75 positive, sclerodactyly, Raynaud's phenomenon) and concurrent pulmonary sarcoidosis with hepatic involvement. At multidisciplinary reassessment, NVC revealed tortuous and crossed capillaries, rare inverted apex, rare giant capillaries, slowed flow, oedema, and sparse neoangiogenesis, in the absence of microhaemorrhages -- a mixed pattern compatible with sarcoidosis/SSc overlap and distinguishable from isolated SSc. Rheumatological assessment confirmed SSc in clinical stability; NT-proBNP had markedly improved from 1222 pg/ml to 148 pg/ml at the current reassessment (2.5 years later), indicating significant haemodynamic improvement under combined therapy. Chest HRCT was substantially unchanged. Conclusion: This case illustrates the diagnostic value of NVC in characterizing microvascular involvement in sarcoidosis/SSc overlap. NVC can distinguish the overlap pattern from isolated SSc, support longitudinal disease monitoring, and contribute to the multidisciplinary management of this rare condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.